AR231533A1 - Un procedimiento para preparar derivados de 3-amino-alquel-1h-indol-5-il metano-sulfonamida - Google Patents

Un procedimiento para preparar derivados de 3-amino-alquel-1h-indol-5-il metano-sulfonamida

Info

Publication number
AR231533A1
AR231533A1 AR290026A AR29002682A AR231533A1 AR 231533 A1 AR231533 A1 AR 231533A1 AR 290026 A AR290026 A AR 290026A AR 29002682 A AR29002682 A AR 29002682A AR 231533 A1 AR231533 A1 AR 231533A1
Authority
AR
Argentina
Prior art keywords
alquel
indol
methane
amino
preparing
Prior art date
Application number
AR290026A
Other languages
English (en)
Spanish (es)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of AR231533A1 publication Critical patent/AR231533A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR290026A 1980-08-12 1982-07-20 Un procedimiento para preparar derivados de 3-amino-alquel-1h-indol-5-il metano-sulfonamida AR231533A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8026288 1980-08-12

Publications (1)

Publication Number Publication Date
AR231533A1 true AR231533A1 (es) 1984-12-28

Family

ID=10515412

Family Applications (1)

Application Number Title Priority Date Filing Date
AR290026A AR231533A1 (es) 1980-08-12 1982-07-20 Un procedimiento para preparar derivados de 3-amino-alquel-1h-indol-5-il metano-sulfonamida

Country Status (28)

Country Link
US (2) US4672067A (OSRAM)
JP (1) JPS5759864A (OSRAM)
AR (1) AR231533A1 (OSRAM)
AT (1) AT381304B (OSRAM)
AU (1) AU548270B2 (OSRAM)
BE (1) BE889930A (OSRAM)
CA (2) CA1169077A (OSRAM)
CH (1) CH651550A5 (OSRAM)
DE (1) DE3131748A1 (OSRAM)
DK (1) DK157680C (OSRAM)
ES (2) ES504695A0 (OSRAM)
FI (1) FI812475A7 (OSRAM)
FR (1) FR2488605A1 (OSRAM)
GB (1) GB2081717B (OSRAM)
GR (1) GR74536B (OSRAM)
IE (1) IE51492B1 (OSRAM)
IL (1) IL63541A (OSRAM)
IT (1) IT1171451B (OSRAM)
LU (1) LU83546A1 (OSRAM)
MY (1) MY8600577A (OSRAM)
NL (1) NL8103768A (OSRAM)
NO (1) NO812722L (OSRAM)
NZ (1) NZ197997A (OSRAM)
PH (1) PH17428A (OSRAM)
PT (1) PT73503B (OSRAM)
SE (1) SE454881B (OSRAM)
ZA (1) ZA815539B (OSRAM)
ZW (1) ZW19381A1 (OSRAM)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
HU196752B (en) * 1983-12-06 1989-01-30 Glaxo Group Ltd Process for production of medical compositions containing indole-derivatives and these compounds
GB8332434D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Production of chemical compounds
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
US4833153A (en) * 1985-11-08 1989-05-23 Glaxo Group Limited Indole derivatives
GB8530507D0 (en) * 1985-12-11 1986-01-22 Glaxo Group Plc Chemical compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8600398D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
US5270333A (en) * 1986-01-28 1993-12-14 Glaxo Group Limited Indole derivatives
GB8607824D0 (en) * 1986-03-27 1986-04-30 Glaxo Group Ltd Chemical compounds
DE3613623A1 (de) * 1986-04-23 1987-10-29 Bayer Ag N-dihydroindolylethyl-sulfonamide
GB8615599D0 (en) * 1986-06-26 1986-07-30 Glaxo Group Ltd Chemical compounds
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
KR100215627B1 (ko) * 1990-06-07 1999-08-16 레슬리 제인 에드워즈 치료용 헤테로사이클 화합물
GB9022250D0 (en) * 1990-10-12 1990-11-28 Glaxo Group Ltd Medicaments
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
CA2091562C (en) * 1990-10-15 2001-03-27 John Eugene Macor Indole derivatives useful in psychotherapeutics
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
ES2033577B1 (es) * 1991-06-06 1995-01-16 Quimica Sint S A Con El 50 Procedimiento para la obtencion de la 2-carboxi-3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida y sus esteres alquilicos inferiores.
ES2033578B1 (es) * 1991-06-06 1995-01-16 Quimica Sint S A Con El 50 Procedimiento para la obtencion de 3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida.
GB9209882D0 (en) * 1992-05-07 1992-06-24 Glaxo Lab Sa Compositions
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them
CA2169179C (en) * 1993-08-31 2000-02-29 John E. Macor 5-arylindole derivatives
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
AU7261196A (en) * 1995-10-10 1997-04-30 Eli Lilly And Company N-{2-substituted-3-(2-aminoethyl)-1h-indol-5-yl}-amides: new 5-ht1f agonists
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
US7026364B2 (en) * 2001-04-13 2006-04-11 Organo Corporation Ion exchanger
JP5833804B2 (ja) * 2005-04-13 2015-12-16 ニューラクソン，インコーポレーテッド Ｎｏｓ阻害活性を有する置換インドール化合物
WO2017004501A1 (en) 2015-07-02 2017-01-05 Civitas Therapeutics, Inc. Triptan powders for pulmonary delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870162A (en) * 1954-04-28 1959-01-20 Upjohn Co Production of certain tryptamines and compounds produced in the process
BE632051A (fr) * 1963-05-08 1963-11-18 Sandoz Sa Nouveaux dérivés de l'indole et leur préparation.
CH442303A (de) * 1964-06-26 1967-08-31 Sandoz Ag Verfahren zur Herstellung von neuen Indol-Derivaten
US3472870A (en) * 1966-08-29 1969-10-14 Mead Johnson & Co Sulfonamidotryptamines
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
US4180509A (en) * 1977-07-01 1979-12-25 Merrell Toraude Et Compagnie α-Ethynyl tryptophanes
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
MY8600577A (en) 1986-12-31
NZ197997A (en) 1985-08-16
ZW19381A1 (en) 1983-03-09
CA1169429A (en) 1984-06-19
DK357181A (da) 1982-02-13
AT381304B (de) 1986-09-25
BE889930A (fr) 1982-02-11
IE811831L (en) 1982-02-12
IT8149086A0 (it) 1981-08-11
DE3131748C2 (OSRAM) 1992-04-23
US4636521A (en) 1987-01-13
GB2081717B (en) 1983-09-28
SE8104782L (sv) 1982-02-13
PT73503A (en) 1981-09-01
JPH0148895B2 (OSRAM) 1989-10-20
IL63541A (en) 1985-08-30
ZA815539B (en) 1983-03-30
FR2488605A1 (fr) 1982-02-19
ES513935A0 (es) 1984-04-16
DK157680C (da) 1990-07-09
FR2488605B1 (OSRAM) 1984-11-16
CH651550A5 (fr) 1985-09-30
PT73503B (en) 1983-09-14
GR74536B (OSRAM) 1984-06-29
DK157680B (da) 1990-02-05
ES8300700A1 (es) 1982-11-01
CA1169077A (en) 1984-06-12
ATA352881A (de) 1986-02-15
IT1171451B (it) 1987-06-10
PH17428A (en) 1984-08-20
NO812722L (no) 1982-02-15
ES504695A0 (es) 1982-11-01
FI812475L (fi) 1982-02-13
US4672067A (en) 1987-06-09
IT8149086A1 (it) 1983-02-11
AU548270B2 (en) 1985-12-05
LU83546A1 (fr) 1983-06-08
NL8103768A (nl) 1982-03-01
JPS5759864A (en) 1982-04-10
SE454881B (sv) 1988-06-06
FI812475A7 (fi) 1982-02-13
GB2081717A (en) 1982-02-24
IE51492B1 (en) 1987-01-07
DE3131748A1 (de) 1982-04-01
AU7399681A (en) 1982-02-18
ES8404327A1 (es) 1984-04-16

Similar Documents

Publication Publication Date Title
ES520104A0 (es) Un procedimiento para preparar derivados de nicotinamida.
AR227533A1 (es) Un procedimiento para producir derivados fenetilaminicos sufamoil sustituidos
ES505373A0 (es) Un metodo para preparar derivados de fenilpiperazina
ES546916A0 (es) Un procedimiento para preparar derivados de guanina
ES530916A0 (es) Un procedimiento para preparar derivados de pirimidina
ES502276A0 (es) Procedimiento para preparar derivados de piridoxina
ES505898A0 (es) Procedimiento para preparar derivados de pirimidona
ES530024A0 (es) Un procedimiento para preparar derivados de pirazinona
ES537104A0 (es) Un procedimiento para preparar derivados de tiazina
ES503091A0 (es) Un procedimiento para obtener derivados de benzopirano
ES528304A0 (es) Un procedimiento para preparar derivados de pirimidona
ES528003A0 (es) Un procedimiento para preparar derivados de cefem
ES548409A0 (es) Un procedimiento para preparar derivados de bencimidazol
ES535568A0 (es) Un procedimiento para preparar derivados de piridazinona
ES505656A0 (es) Un procedimiento para preparar nuevos derivados de antraci- clina
ES502026A0 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
ES507975A0 (es) Un metodo para preparar derivados de pirazolina.
ES519936A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES500796A0 (es) Procedimiento para preparar derivados de pirimidona
ES538036A0 (es) Un procedimiento para preparar derivados de piridona.
ES526177A0 (es) Un procedimiento para preparar derivados de pirimidona
ES506302A0 (es) Un procedimiento para preparar derivados de tetrahidroiso- quinoleinas
ES500478A0 (es) Un procedimiento para obtener derivados de biciclooctano
ES506930A0 (es) Un procedimiento para preparar derivados de n-fenil-dicloro-maleimida.
ES530855A0 (es) Un procedimiento para preparar derivados de benzotiazina